The duPont REGISTRY Group (DRG) has formed a partnership with Fortune International Group and the iconic Pininfarina to build ...

Although getting on the ground floor could provide outsize returns for such investments, Dupont said, the risk often outweighs the potential reward. Umoja CEO Andy Scharenberg, meanwhile ...

The Hotel DuPont is a familiar stay, and I've bought too many shirts ... state on Monday proposed amending a bill that would limit investor lawsuits by allowing corporate boards to further insulate ...

The first-of-its-kind tower will be built for a group of exclusive car collectors. duPont REGISTRY Group (DRG), the ...

JPMorgan Chase JPM.N said on Thursday that long-serving CEO Jamie Dimon's 2024 pay package climbed about 8.3% to $39 million after the bank posted a record profit amid a revival in dealmaking ...

These days, though, Simon is feeling uneasy as a growing number of prominent business leaders like Elon Musk and Bill Ackman, ...

The S&P 500 eked out a gain of less than 0.1% on Tuesday, Feb. 11, as investors digested testimony from the Fed chair and awaited Wednesday's CPI report.

DuPont is in solid financial condition. As of Dec. 31, we calculate a net debt/adjusted EBITDA ratio of around 1.7, a little below management's long-term target of around 2 times. DuPont acquired ...

www.dupont.com) has appointed interim chairman and chief executive Edward Breen to permanently fill the position. Breen, regarded as a turnaround specialist, joined the board in February, and took ...

Anthropic Chief Executive Officer Dario Amodei said that his AI startup is racing to secure the computing power needed to meet demand for its generative AI chatbot Claude. “The surge in demand ...

Antoine Dupont, returning to Six Nations action having missed last year’s tournament to prepare for the Paris Olympics, stole the show with a masterful, all-court performance. However ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.